Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies Article Swipe
Julián Panés
,
Séverine Vermeire
,
James O. Lindsay
,
Bruce E. Sands
,
Chinyu Su
,
Gary S. Friedman
,
Haiying Zhang
,
Aaron Yarlas
,
Martha Bayliss
,
Stephen Maher
,
Joseph C. Cappelleri
,
Andrew G. Bushmakin
,
David T. Rubin
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjy135
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjy135
Related Topics
Concepts
Metadata
- Type
- erratum
- Language
- en
- Landing Page
- https://doi.org/10.1093/ecco-jcc/jjy135
- https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf
- OA Status
- hybrid
- Cited By
- 13
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4229935304
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4229935304Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ecco-jcc/jjy135Digital Object Identifier
- Title
-
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance StudiesWork title
- Type
-
erratumOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-11-08Full publication date if available
- Authors
-
Julián Panés, Séverine Vermeire, James O. Lindsay, Bruce E. Sands, Chinyu Su, Gary S. Friedman, Haiying Zhang, Aaron Yarlas, Martha Bayliss, Stephen Maher, Joseph C. Cappelleri, Andrew G. Bushmakin, David T. RubinList of authors in order
- Landing page
-
https://doi.org/10.1093/ecco-jcc/jjy135Publisher landing page
- PDF URL
-
https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdfDirect OA link when available
- Concepts
-
Tofacitinib, Ulcerative colitis, Medicine, Quality of life (healthcare), Internal medicine, Health maintenance, Randomized controlled trial, Colitis, Health care, Disease, Rheumatoid arthritis, Nursing, Economics, Economic growthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
13Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 2, 2023: 3, 2022: 1, 2021: 1, 2020: 5Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4229935304 |
|---|---|
| doi | https://doi.org/10.1093/ecco-jcc/jjy135 |
| ids.doi | https://doi.org/10.1093/ecco-jcc/jjy135 |
| ids.openalex | https://openalex.org/W4229935304 |
| fwci | 1.23599054 |
| type | erratum |
| title | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| biblio.issue | 1 |
| biblio.volume | 13 |
| biblio.last_page | 140 |
| biblio.first_page | 139 |
| topics[0].id | https://openalex.org/T10134 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9993000030517578 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Inflammatory Bowel Disease |
| topics[1].id | https://openalex.org/T13569 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9986000061035156 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Microscopic Colitis |
| topics[2].id | https://openalex.org/T12578 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9843000173568726 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Diagnosis and treatment of tuberculosis |
| is_xpac | False |
| apc_list.value | 3881 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4185 |
| apc_paid.value | 3881 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4185 |
| concepts[0].id | https://openalex.org/C2778886723 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9534835815429688 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q3530324 |
| concepts[0].display_name | Tofacitinib |
| concepts[1].id | https://openalex.org/C2780479503 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8981055021286011 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1477 |
| concepts[1].display_name | Ulcerative colitis |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.7200882434844971 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2779951463 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5218021869659424 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7268788 |
| concepts[3].display_name | Quality of life (healthcare) |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4764041006565094 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2992556508 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4716046452522278 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12147 |
| concepts[5].display_name | Health maintenance |
| concepts[6].id | https://openalex.org/C168563851 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4329884648323059 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[6].display_name | Randomized controlled trial |
| concepts[7].id | https://openalex.org/C2775862500 |
| concepts[7].level | 2 |
| concepts[7].score | 0.41966331005096436 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2453464 |
| concepts[7].display_name | Colitis |
| concepts[8].id | https://openalex.org/C160735492 |
| concepts[8].level | 2 |
| concepts[8].score | 0.1643187701702118 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q31207 |
| concepts[8].display_name | Health care |
| concepts[9].id | https://openalex.org/C2779134260 |
| concepts[9].level | 2 |
| concepts[9].score | 0.13373354077339172 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[9].display_name | Disease |
| concepts[10].id | https://openalex.org/C2777575956 |
| concepts[10].level | 2 |
| concepts[10].score | 0.09099790453910828 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q187255 |
| concepts[10].display_name | Rheumatoid arthritis |
| concepts[11].id | https://openalex.org/C159110408 |
| concepts[11].level | 1 |
| concepts[11].score | 0.056940555572509766 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[11].display_name | Nursing |
| concepts[12].id | https://openalex.org/C162324750 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[12].display_name | Economics |
| concepts[13].id | https://openalex.org/C50522688 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q189833 |
| concepts[13].display_name | Economic growth |
| keywords[0].id | https://openalex.org/keywords/tofacitinib |
| keywords[0].score | 0.9534835815429688 |
| keywords[0].display_name | Tofacitinib |
| keywords[1].id | https://openalex.org/keywords/ulcerative-colitis |
| keywords[1].score | 0.8981055021286011 |
| keywords[1].display_name | Ulcerative colitis |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.7200882434844971 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/quality-of-life |
| keywords[3].score | 0.5218021869659424 |
| keywords[3].display_name | Quality of life (healthcare) |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.4764041006565094 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/health-maintenance |
| keywords[5].score | 0.4716046452522278 |
| keywords[5].display_name | Health maintenance |
| keywords[6].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[6].score | 0.4329884648323059 |
| keywords[6].display_name | Randomized controlled trial |
| keywords[7].id | https://openalex.org/keywords/colitis |
| keywords[7].score | 0.41966331005096436 |
| keywords[7].display_name | Colitis |
| keywords[8].id | https://openalex.org/keywords/health-care |
| keywords[8].score | 0.1643187701702118 |
| keywords[8].display_name | Health care |
| keywords[9].id | https://openalex.org/keywords/disease |
| keywords[9].score | 0.13373354077339172 |
| keywords[9].display_name | Disease |
| keywords[10].id | https://openalex.org/keywords/rheumatoid-arthritis |
| keywords[10].score | 0.09099790453910828 |
| keywords[10].display_name | Rheumatoid arthritis |
| keywords[11].id | https://openalex.org/keywords/nursing |
| keywords[11].score | 0.056940555572509766 |
| keywords[11].display_name | Nursing |
| language | en |
| locations[0].id | doi:10.1093/ecco-jcc/jjy135 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735960814 |
| locations[0].source.issn | 1873-9946, 1876-4479 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1873-9946 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Crohn s and Colitis |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Crohn's and Colitis |
| locations[0].landing_page_url | https://doi.org/10.1093/ecco-jcc/jjy135 |
| locations[1].id | pmh:oai:europepmc.org:5276579 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306400806 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Europe PMC (PubMed Central) |
| locations[1].source.host_organization | https://openalex.org/I1303153112 |
| locations[1].source.host_organization_name | European Bioinformatics Institute |
| locations[1].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6302951 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5040354010 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4971-6902 |
| authorships[0].author.display_name | Julián Panés |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210115097, https://openalex.org/I4210132431, https://openalex.org/I4210160192 |
| authorships[0].affiliations[0].raw_affiliation_string | Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210132431 |
| authorships[0].institutions[0].ror | https://ror.org/03cn6tr16 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210132431 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas |
| authorships[0].institutions[1].id | https://openalex.org/I4210160192 |
| authorships[0].institutions[1].ror | https://ror.org/054vayn55 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[0].institutions[2].id | https://openalex.org/I4210115097 |
| authorships[0].institutions[2].ror | https://ror.org/02a2kzf50 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210115097 |
| authorships[0].institutions[2].country_code | ES |
| authorships[0].institutions[2].display_name | Hospital Clínic de Barcelona |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Julian Panés |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain |
| authorships[1].author.id | https://openalex.org/A5019474609 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9942-3019 |
| authorships[1].author.display_name | Séverine Vermeire |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Séverine Vermeire |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium |
| authorships[2].author.id | https://openalex.org/A5055734737 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3353-9590 |
| authorships[2].author.display_name | James O. Lindsay |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I166337079 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK |
| authorships[2].institutions[0].id | https://openalex.org/I166337079 |
| authorships[2].institutions[0].ror | https://ror.org/026zzn846 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I166337079 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Queen Mary University of London |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | James O Lindsay |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK |
| authorships[3].author.id | https://openalex.org/A5017140014 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5762-5042 |
| authorships[3].author.display_name | Bruce E. Sands |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I98704320 |
| authorships[3].affiliations[0].raw_affiliation_string | Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| authorships[3].institutions[0].id | https://openalex.org/I98704320 |
| authorships[3].institutions[0].ror | https://ror.org/04a9tmd77 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I1320796813, https://openalex.org/I98704320 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Icahn School of Medicine at Mount Sinai |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Bruce E Sands |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| authorships[4].author.id | https://openalex.org/A5112890618 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Chinyu Su |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[4].affiliations[0].raw_affiliation_string | Pfizer Inc, Collegeville, PA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I180857899 |
| authorships[4].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Pfizer (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Chinyu Su |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Pfizer Inc, Collegeville, PA, USA |
| authorships[5].author.id | https://openalex.org/A5035586844 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2479-328X |
| authorships[5].author.display_name | Gary S. Friedman |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[5].affiliations[0].raw_affiliation_string | Pfizer Inc, Collegeville, PA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I180857899 |
| authorships[5].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Pfizer (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gary Friedman |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Pfizer Inc, Collegeville, PA, USA |
| authorships[6].author.id | https://openalex.org/A5100764104 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-9592-8669 |
| authorships[6].author.display_name | Haiying Zhang |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[6].affiliations[0].raw_affiliation_string | Pfizer Inc, Collegeville, PA, USA |
| authorships[6].institutions[0].id | https://openalex.org/I180857899 |
| authorships[6].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Pfizer (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Haiying Zhang |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Pfizer Inc, Collegeville, PA, USA |
| authorships[7].author.id | https://openalex.org/A5009122387 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4600-259X |
| authorships[7].author.display_name | Aaron Yarlas |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210124242 |
| authorships[7].affiliations[0].raw_affiliation_string | Optum, Lincoln, RI, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210124242 |
| authorships[7].institutions[0].ror | https://ror.org/0370sjj75 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210124242 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Optum (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Aaron Yarlas |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Optum, Lincoln, RI, USA |
| authorships[8].author.id | https://openalex.org/A5050799761 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8213-9000 |
| authorships[8].author.display_name | Martha Bayliss |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210124242 |
| authorships[8].affiliations[0].raw_affiliation_string | Optum, Lincoln, RI, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210124242 |
| authorships[8].institutions[0].ror | https://ror.org/0370sjj75 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210124242 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Optum (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Martha Bayliss |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Optum, Lincoln, RI, USA |
| authorships[9].author.id | https://openalex.org/A5066806233 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3364-9458 |
| authorships[9].author.display_name | Stephen Maher |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210124242 |
| authorships[9].affiliations[0].raw_affiliation_string | Optum, Lincoln, RI, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210124242 |
| authorships[9].institutions[0].ror | https://ror.org/0370sjj75 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210124242 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Optum (United States) |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Stephen Maher |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Optum, Lincoln, RI, USA |
| authorships[10].author.id | https://openalex.org/A5091669022 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-9586-0748 |
| authorships[10].author.display_name | Joseph C. Cappelleri |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[10].affiliations[0].raw_affiliation_string | Pfizer Inc, Groton, CT, USA |
| authorships[10].institutions[0].id | https://openalex.org/I180857899 |
| authorships[10].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Pfizer (United States) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Joseph C Cappelleri |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Pfizer Inc, Groton, CT, USA |
| authorships[11].author.id | https://openalex.org/A5031955903 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Andrew G. Bushmakin |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[11].affiliations[0].raw_affiliation_string | Pfizer Inc, Groton, CT, USA |
| authorships[11].institutions[0].id | https://openalex.org/I180857899 |
| authorships[11].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Pfizer (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Andrew G Bushmakin |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Pfizer Inc, Groton, CT, USA |
| authorships[12].author.id | https://openalex.org/A5108771423 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5647-1723 |
| authorships[12].author.display_name | David T. Rubin |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I40347166 |
| authorships[12].affiliations[0].raw_affiliation_string | The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA |
| authorships[12].institutions[0].id | https://openalex.org/I40347166 |
| authorships[12].institutions[0].ror | https://ror.org/024mw5h28 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I40347166 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | University of Chicago |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | David T Rubin |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10134 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9993000030517578 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Inflammatory Bowel Disease |
| related_works | https://openalex.org/W2800736652, https://openalex.org/W4232564400, https://openalex.org/W4206006744, https://openalex.org/W3027165253, https://openalex.org/W4244336819, https://openalex.org/W4252091638, https://openalex.org/W2946759634, https://openalex.org/W4362586891, https://openalex.org/W1968341287, https://openalex.org/W3035822871 |
| cited_by_count | 13 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 5 |
| counts_by_year[5].year | 2019 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ecco-jcc/jjy135 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735960814 |
| best_oa_location.source.issn | 1873-9946, 1876-4479 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1873-9946 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Crohn s and Colitis |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Crohn's and Colitis |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjy135 |
| primary_location.id | doi:10.1093/ecco-jcc/jjy135 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735960814 |
| primary_location.source.issn | 1873-9946, 1876-4479 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1873-9946 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Crohn s and Colitis |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Crohn's and Colitis |
| primary_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjy135 |
| publication_date | 2018-11-08 |
| publication_year | 2018 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 13 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5600000023841858 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.82945822 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |